Urological malignancy Flashcards
What is the most common kidney cancer?
Renal call carcinoma - 90% of renal cancers
e.g. adenocarcinoma proximal renal tubular epithelium
- M>F @ 2:1
- ~55y/o
- 15% haemodialysis patients
- 50% incidental findings (e.g. on CT etc)
clear cell renal cell carcinoma is most commont type of RCC (
How does kidney cancer present?
- -haematuria, loin pain, abdominal mass,
- anorexia, malaise, weight loss, fever
- varicocele (invasion of L renal vein compressing L testicular)
- spread: bone, liver, lung
- paraneoplastic syndromes e.g. EPO producing
What are the investigatons of kidney cancer?
- ↑BP (renin)
- Polycythaemia (EPO), ↑ALP (mets)
- Urine cytology
- USS/CT/MRI,
- CT renal protocol,
- DMSA (nuclear med for renal morphology)
- CXR (cannon ball metastases)
What is the management of T1a (<4cm in kid), T2-3 (tumour inside kidney but 7cm+) and metastatic renal carcinoma?
(staging)
(T1a) Renal preservation if possible - active surveillance, cryotherapy, partial nephrectomy
Radical nephrectomy (T2-3)
Metastatic disease - tyrosine kinase inhibitors, cytoreductive nephrectomy (remove–>systemic Tx)
What is a nephrobalstoma/Wilms tumour?
Chief abdominal malignancy in children
(primitive renal tubules and mesenchymal cells)
Presents with (1) abdo mass and (2) haematuria - NO abdo pain
What are the cancers of the renal pelvis –> bladder called?
transitional cell carcinoma
- 50% are in the bladder
- of bladder cancers - 90% are transitional cell carcinoma
- ~40y/o and M>F 4:1
squamous cell carcinoma is 2nd most common e.g. RD schistosomiasis & long term catherterisation
What is the presentation of transitional cell carcinoma aka urothelial e.g. renal pelvis-bladder cancers?
- Painless haematuria, frequency, urgency, dysuria, urinary tract obstruction, recurrent UTIs
- Hx:
- smoking, aromatic amines (rubber industry), chronic cystitis, schistosomiasis (SCC), pelvis irradiation
- Spread:
- local, lymphatic, liver & lungs
Remeber RF = industrial dye/solvents/rubber/textile/plastic workers & cigarrete smoking
What Ix are done for transitional cell carcinoma/cancer of renal pelvis–>bladder?
- USS or CT/MRI
- urine cytology (urothelium readuly sheds)
- flexible cystoscopy + biopsy,
- Intravenous urography (IVU)
What is the management of Tis/Ta/T1 transitional cell carcinoma?
NB: Tis/Ta and T1 are 80% of all TCC patients; not invaded detrusor musc just mucosa
papillary architecture
high recurrence though
- TURBT - diathermy
- reg follow up w/cystoscope and urine cytology
- Ta = surveillance
- Intravesical chemotherapy (intermediate risk - multiple large, reccurenct)
- Intravesical BCG immunotherapy (high risk eg T1 or CIS/Tis)
What is the management of T2-3 Transitional cell carcinoma?
e.g. spread to detrusor/renal parenchyma/ fat/msucle surrounding; look solid over papillary
- Radical cystectomy
- & urinary diversion
- (chemo)Radiotherapy - worse survival but preserves bladder
- Neoadjuvant chemo e.g. then surg
What is the management of T4 Transitional cell carcinoma?
NB: T4 = abdo/pelvic wall spread, prostate/vagina etc spread
- Palliative chemo/radiotherapy,
- chronic catheterisation & urinary diversions to help relieve pain
What is the name of prostate cancer?
Adenocarcinoma
- most common male malignancy,
- 80% in men >80yrs;
- peripheral zone of the prostate
What is the presentation of prostate adenocarcinoma?
- asymptomatic OR
- nocturia, hesitancy, poor stream, terminal dribbling,
- weight loss +/- bone pain suggests mets
- nocturia, hesitancy, poor stream, terminal dribbling,
- -associated with family hx & ↑testosterone
- -spread: locally or to bone
What investigations can be done for prostate cancer?
- DRE (hard, irregular),
- PSA↑ (+consider trend and age related e.g. over 4 is abnormal),
- transrectal USS & biopsy (prophylactic ciprofloxacin for infection),
- x-rays, bone scan,
- CT, MRI (staging)
Prognosis: PSA level, stage & grade
What is the treatment for prostate-confined disease?
(adenocarcinoma)
- Radical prostatectomy (<70yrs)
- Radical radiotherapy (+/- neoadjuvant hormonal therapy)
- Hormone therapy (delays progression)
- Active surveillance (>70yrs & low risk)